HUTCHMED (China) Limited (HK:0013) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
HUTCHMED (China) Limited has announced its blocklisting six monthly return, highlighting that during the period from June to December 2024, 241,375 ordinary shares were issued under the 2015 Share Option Scheme. The company, known for its innovative cancer and immunology therapies, maintains a robust pipeline with 871,601,095 shares currently in issue.
For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.
